Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Mar 19, 2017, 14:00 ET Analyses Of PCSK9 Inhibitor Prescription Rejection Rates Demonstrate Significant Access Barriers For Appropriate Patients

Amgen (NASDAQ:AMGN) today announced new data from two studies that showed that for appropriate patients (on-label) in the U.S., the majority of...


Mar 19, 2017, 14:00 ET Late-Breaking Data Shows the CardioMEMS HF System is Effective in Reducing Heart Failure Hospitalizations and Cost of Care

New late-breaking featured clinical research presented today adds strong clinical support for Abbott's CardioMEMS™ HF System as an effective...


Mar 19, 2017, 10:45 ET Uninterrupted Pradaxa® (dabigatran etexilate mesylate) Showed Less Major Bleeding than Warfarin in Atrial Fibrillation Patients Undergoing Catheter Ablation

Important new data from the RE-CIRCUIT® study show a better safety profile for Pradaxa® (dabigatran etexilate mesylate) compared to warfarin in...


Mar 18, 2017, 12:30 ET Late-Breaking Data on Abbott's MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease

Abbott (NYSE: ABT) today announced favorable one-year outcomes from the largest study of real-world experience for the MitraClip system in...


Mar 18, 2017, 11:30 ET Clinical trials demonstrate benefits of instant wave-free ratio (iFR) compared to fractional flow reserve (FFR) for the assessment of coronary artery disease

Royal Philips (NYSE: PHG, AEX: PHIA) today announced that the results from two large clinical trials comparing patient outcomes using instant...


Mar 18, 2017, 09:48 ET New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes

Novartis announced today results of a new post-hoc analysis in a subgroup of patients with reduced ejection fraction heart failure (HFrEF) and...


Mar 18, 2017, 08:13 ET New Phase 3 Study Finds XARELTO® to Be Superior to Aspirin for Long-Term Prevention of Recurrent Blood Clots Without Observing any Significant Increase in Major Bleeding in Patients with Venous Thromboembolism

Janssen Pharmaceuticals, Inc. (Janssen) today announced new Phase 3 results from EINSTEIN CHOICE showing patients with venous thromboembolism (VTE)...


Mar 18, 2017, 08:00 ET Lowering LDL Levels With Repatha® (Evolocumab) Did Not Adversely Affect Cognitive Function In Landmark Phase 3 Study

Amgen (NASDAQ:AMGN) today announced detailed results from the Repatha® (evolocumab) cognitive function trial (EBBINGHAUS) evaluating the impact on...


Mar 17, 2017, 19:46 ET SBRT offers curative option for lung cancer patients age 80 and older

Patients in their 80s and 90s who have early stage lung cancer but cannot undergo an operation can be treated safely and effectively with...


Mar 17, 2017, 19:25 ET Biomarker blood test shows cancer recurrence months before CT scans

Results from a prospective clinical trial showed that a blood test looking at specific biomarkers was able to detect recurrences of lung cancer an...


Mar 17, 2017, 16:00 ET Intec Pharma to Participate in the Oppenheimer 27th Annual Healthcare Conference

Intec Pharma Ltd. (NASDAQ: NTEC), a late stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™...


Mar 17, 2017, 14:01 ET Knee Pain and Stem Cells: What does the future look like?

Medicine is constantly changing. The same is true for stem cell science and Regenerative Medicine in general. The knee has arguably been given the...


Mar 17, 2017, 11:26 ET Agentes de contraste con gadolinio: actualización de las recomendaciones del PRAC

Guerbet (FR0000032526 GBT), un especialista mundial en productos y soluciones de contraste para imágenes médicas, toma conocimiento...


Mar 17, 2017, 10:00 ET Multicenterstudie med Acarix CADScor®System bekräftar tidigare preliminära resultat att CADScor®System kan utesluta CAD med 97% negativt prediktivt värde

Idag tillkännagav Acarix AB (publ) ("Acarix"x) resultaten från en ny multicenterstudie med det handhållna CADScor®System för icke-invasiv och...


Mar 17, 2017, 10:00 ET Ergebnisse einer multizentrischen Studie am Acarix CADScor®System bestätigen einen 97%igen negativem Vorhersagewert für den Ausschluss einer koronaren Herzkrankheit

Acarix AB (Publ) ("Acarix") hat heute die Ergebnisse einer neuen multizentrischen Studie zu seinem CADScor®System für eine nicht-invasive,...


Mar 17, 2017, 10:00 ET Acarix CADScor®System Multi-center Trial Results Confirm Previous Preliminary Results Ruling out CAD With 97% Negative Predictive Value

Acarix AB (publ) ("Acarix") today announced the results from a new multi-center trial of its handheld CADScor®System for non-invasive,...


Mar 17, 2017, 09:00 ET Landmark Outcomes Study Shows That Repatha® (Evolocumab) Decreases LDL-C To Unprecedented Low Levels And Reduces Risk Of Cardiovascular Events With No New Safety Issues

Amgen (NASDAQ:AMGN) today announced that the 27,564-patient Repatha® (evolocumab) cardiovascular outcomes study, FOURIER, established for the first...


Mar 17, 2017, 09:00 ET Topix Announces New Age Defying Retinol Treatment Serum

Topix Pharmaceuticals, Inc. has announced the newest retinol serum in their portfolio, Replenix® RetinolForte Treatment Serum, helping to diminish...


Mar 17, 2017, 09:00 ET Medical Marijuana, Inc.'s CBD Oil RSHO-X™ Garners National News Headlines Across Mexico For Significantly Reducing Seizures Of Epileptic Children

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary...


Mar 17, 2017, 08:30 ET Worldwide Clinical Trials Expert to Present at the American Academy of Pain Medicine Annual Meeting

Miroslav Backonja, M.D., Senior Medical Director at Worldwide Clinical Trials (http://www.worldwide.com), will be presenting two sessions at the...


Mar 17, 2017, 08:00 ET First dedicated outcome trials of empagliflozin in chronic heart failure initiated

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that the EMPEROR HF clinical trial program was initiated. EMPEROR HF...


Mar 17, 2017, 07:00 ET Resverlogix Announces Third Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone and Provides an Update on Corporate Activities

A data review by the independent Data Safety Monitoring Board resulted in a recommendation for the BETonMACE trial to continue as planned without...


Mar 17, 2017, 03:01 ET Degree of Spinal Deformity Affects Hip Replacement Surgery Success

People with spinal deformity also requiring a total hip replacement are at greater risk for dislocation or follow-up revision surgery, suggesting...


Mar 17, 2017, 02:10 ET Nordic Nanovector Announces First Patient Dosed in Phase 1 Study of Betalutin® in Diffuse Large B-cell Lymphoma (DLBCL), an Aggressive Form of NHL

Nordic Nanovector ASA (OSE: NANO) announces that the first patient has been dosed in its Phase 1 study evaluating Betalutin®...


Mar 16, 2017, 16:05 ET aTyr Pharma Announces Fourth Quarter and Year-End 2016 Operating Results

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address...